The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Choose Philadelphia Business Journal as a preferred news source to see more of our reporting on Google. The 6-year-old ...

The latest update is out from PDS Biotechnology ( (PDSB) ).

The incidence of HPV16-related cancers is rapidly increasing in the US and Europe and also increasing globally.* PDS0101 is currently being studied in the Company’s Phase 3 trial for PDS0101 + ...

Incyte's data bolster efforts to develop a new type of drug for myelofibrosis, and suggest it may be a replacement for Jakafi ...

New Haven clinical-stage drug developer Trevi Therapeutics Inc. announced that David Hastings has been hired as its new CFO.

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Students at centers like BioTC in OKC and other locations are training to step into jobs that didn’t even exist a decade ago ...

At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...

China's Sichuan Kelun-Biotech Biopharmaceutical (6990.HK) said Thursday night it would license an experimental cancer ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...